Found: 13
Select item for more details and to access through your institution.
Correction to: Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction to: Maralixibat: First Approval.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Drug Treatment of Cluster Headache.
- Published in:
- Drugs, 2022, v. 82, n. 1, p. 33, doi. 10.1007/s40265-021-01658-z
- By:
- Publication type:
- Article
Optimized Dosing: The Next Step in Precision Medicine in Non-Small-Cell Lung Cancer.
- Published in:
- Drugs, 2022, v. 82, n. 1, p. 15, doi. 10.1007/s40265-021-01654-3
- By:
- Publication type:
- Article
Correction to: Efmoroctocog Alfa: A Review in Haemophilia A.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction to: Infigratinib: First Approval.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Avacopan: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 1, p. 79, doi. 10.1007/s40265-021-01643-6
- By:
- Publication type:
- Article
Maralixibat: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 1, p. 71, doi. 10.1007/s40265-021-01649-0
- By:
- Publication type:
- Article
Chiglitazar: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 1, p. 87, doi. 10.1007/s40265-021-01648-1
- By:
- Publication type:
- Article
Rationale and Clinical Use of Bronchodilators in Adults with Bronchiectasis.
- Published in:
- Drugs, 2022, v. 82, n. 1, p. 1, doi. 10.1007/s40265-021-01646-3
- By:
- Publication type:
- Article
Atogepant: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 1, p. 65, doi. 10.1007/s40265-021-01644-5
- By:
- Publication type:
- Article
Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis.
- Published in:
- Drugs, 2022, v. 82, n. 1, p. 55, doi. 10.1007/s40265-021-01650-7
- By:
- Publication type:
- Article
Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19.
- Published in:
- Drugs, 2022, v. 82, n. 1, p. 43, doi. 10.1007/s40265-021-01639-2
- By:
- Publication type:
- Article